A citation-based method for searching scientific literature

Xiao Zhang, Guigao Lin, Liming Tan, Jinming Li. Biomed Pharmacother 2018
Times Cited: 21







List of co-cited articles
98 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Mercè Brunet, Teun van Gelder, Anders Åsberg, Vincent Haufroid, Dennis A Hesselink, Loralie Langman, Florian Lemaitre, Pierre Marquet, Christoph Seger, Maria Shipkova,[...]. Ther Drug Monit 2019
220
28

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.
K A Birdwell, B Decker, J M Barbarino, J F Peterson, C M Stein, W Sadee, D Wang, A A Vinks, Y He, J J Swen,[...]. Clin Pharmacol Ther 2015
343
23

Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
Fabiana D V Genvigir, Alvaro M Nishikawa, Claudia R Felipe, Helio Tedesco-Silva, Nagilla Oliveira, Antony B C Salazar, Jose O Medina-Pestana, Sonia Q Doi, Mario H Hirata, Rosario D C Hirata. Pharmacotherapy 2017
22
19

FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients.
Zhuo Wu, Qinxia Xu, Xiaoyan Qiu, Zheng Jiao, Ming Zhang, Mingkang Zhong. Eur J Clin Pharmacol 2017
14
21

The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
Agnieszka A Prytuła, Karlien Cransberg, Antonia H M Bouts, Ron H N van Schaik, Huib de Jong, Saskia N de Wildt, Ron A A Mathôt. Clin Pharmacokinet 2016
25
14

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations.
J T Tang, L M Andrews, T van Gelder, Y Y Shi, R H N van Schaik, L L Wang, D A Hesselink. Expert Opin Drug Metab Toxicol 2016
84
14

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation.
Meng Yu, Mouze Liu, Wei Zhang, Yingzi Ming. Curr Drug Metab 2018
60
14

Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management.
Nauras Shuker, Teun van Gelder, Dennis A Hesselink. Transplant Rev (Orlando) 2015
133
14

Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients.
Diego Alberto C Cusinato, Riccardo Lacchini, Elen A Romao, Miguel Moysés-Neto, Eduardo B Coelho. Br J Clin Pharmacol 2014
29
14

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.
Dennis A Hesselink, Ron H N van Schaik, Ilse P van der Heiden, Marloes van der Werf, Peter J H Smak Gregoor, Jan Lindemans, Willem Weimar, Teun van Gelder. Clin Pharmacol Ther 2003
556
14

The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.
Dennis A Hesselink, Rachida Bouamar, Laure Elens, Ron H N van Schaik, Teun van Gelder. Clin Pharmacokinet 2014
163
14

Haploview: analysis and visualization of LD and haplotype maps.
J C Barrett, B Fry, J Maller, M J Daly. Bioinformatics 2005
9

FK506-Binding Proteins and Their Diverse Functions.
Mingming Tong, Yu Jiang. Curr Mol Pharmacol 2015
48
9

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients.
Patricia C Salgado, Fabiana Dv Genvigir, Claudia R Felipe, Helio Tedesco-Silva, Jose O Medina-Pestana, Sonia Q Doi, Mario H Hirata, Rosario Dc Hirata. Pharmgenomics Pers Med 2017
3
66


Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients.
Wei Zhao, May Fakhoury, Véronique Baudouin, Thomas Storme, Anne Maisin, Georges Deschênes, Evelyne Jacqz-Aigrain. Eur J Clin Pharmacol 2013
48
9

Dosing equation for tacrolimus using genetic variants and clinical factors.
Chaitali Passey, Angela K Birnbaum, Richard C Brundage, William S Oetting, Ajay K Israni, Pamala A Jacobson. Br J Clin Pharmacol 2011
120
9

Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach.
Cécile Gérard, Jeanick Stocco, Anne Hulin, Benoit Blanchet, Céline Verstuyft, François Durand, Filomena Conti, Christophe Duvoux, Michel Tod. AAPS J 2014
30
9

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Christine E Staatz, Charlene Willis, Paul J Taylor, Susan E Tett. Clin Pharmacol Ther 2002
118
9

Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients.
Mariam H Abdel Jalil, Ahmed F Hawwa, Patrick J McKiernan, Michael D Shields, James C McElnay. Br J Clin Pharmacol 2014
31
9

Update on the clinical utility of once-daily tacrolimus in the management of transplantation.
Maria Aurora Posadas Salas, Titte R Srinivas. Drug Des Devel Ther 2014
16
12

Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
Pierre Wallemacq, Victor W Armstrong, Merce Brunet, Vincent Haufroid, David W Holt, Atholl Johnston, Dirk Kuypers, Yannick Le Meur, Pierre Marquet, Michael Oellerich,[...]. Ther Drug Monit 2009
344
9

Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
Xiao-cong Zuo, Chee M Ng, Jeffrey S Barrett, Ai-jing Luo, Bi-kui Zhang, Chen-hui Deng, Lan-yan Xi, Ke Cheng, Ying-zi Ming, Guo-ping Yang,[...]. Pharmacogenet Genomics 2013
95
9

The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients.
Jing-Jing Zhang, Shuai-Bing Liu, Ling Xue, Xiao-Liang Ding, Hua Zhang, Li-Yan Miao. Int J Clin Pharmacol Ther 2015
31
9

Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome.
Afsana Jahan, Ratna Prabha, Swasti Chaturvedi, Binu Mathew, Denise Fleming, Indira Agarwal. Pediatr Nephrol 2015
20
10

Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation.
M A Sikma, E M van Maarseveen, E A van de Graaf, J H Kirkels, M C Verhaar, D W Donker, J Kesecioglu, J Meulenbelt. Am J Transplant 2015
88
9

Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.
Nayoung Han, Hwi-yeol Yun, Jin-yi Hong, In-Wha Kim, Eunhee Ji, Su Hyun Hong, Yon Su Kim, Jongwon Ha, Wan Gyoon Shin, Jung Mi Oh. Eur J Clin Pharmacol 2013
58
9


A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.
Franc Andreu, Helena Colom, Laure Elens, Teun van Gelder, Ronald H N van Schaik, Dennis A Hesselink, Oriol Bestard, Joan Torras, Josep M Cruzado, Josep M Grinyó,[...]. Clin Pharmacokinet 2017
57
9

Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
Rogier R Press, Bart A Ploeger, Jan den Hartigh, Tahar van der Straaten, Johannes van Pelt, Meindert Danhof, Johan W de Fijter, Henk-Jan Guchelaar. Ther Drug Monit 2009
101
9

Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
Ken Ogasawara, Shripad D Chitnis, Reginald Y Gohh, Uwe Christians, Fatemeh Akhlaghi. Clin Pharmacokinet 2013
57
9

Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
Flora T Musuamba, Vanessa Guy-Viterbo, Raymond Reding, Roger K Verbeeck, Pierre Wallemacq. Ther Drug Monit 2014
24
9

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
Simon D Harding, Joanna L Sharman, Elena Faccenda, Chris Southan, Adam J Pawson, Sam Ireland, Alasdair J G Gray, Liam Bruce, Stephen P H Alexander, Stephen Anderton,[...]. Nucleic Acids Res 2018
9

Importance of hematocrit for a tacrolimus target concentration strategy.
Elisabet Størset, Nick Holford, Karsten Midtvedt, Sara Bremer, Stein Bergan, Anders Åsberg. Eur J Clin Pharmacol 2014
75
9

Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
Nayoung Han, Soojung Ha, Hwi-yeol Yun, Myeong Gyu Kim, Sang-Il Min, Jongwon Ha, Jangik Ike Lee, Jung Mi Oh, In-Wha Kim. Basic Clin Pharmacol Toxicol 2014
40
9

Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
Johan E Wallin, Martin Bergstrand, Henryk E Wilczek, Per S Nydert, Mats O Karlsson, Christine E Staatz. Ther Drug Monit 2011
31
9

Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients.
Marie Antignac, Benoit Barrou, Robert Farinotti, Philippe Lechat, Saïk Urien. Br J Clin Pharmacol 2007
87
9

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
Louise M Andrews, Dennis A Hesselink, Teun van Gelder, Birgit C P Koch, Elisabeth A M Cornelissen, Roger J M Brüggemann, Ron H N van Schaik, Saskia N de Wildt, Karlien Cransberg, Brenda C M de Winter. Clin Pharmacokinet 2018
40
9

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.
W Zhao, V Elie, G Roussey, K Brochard, P Niaudet, V Leroy, C Loirat, P Cochat, S Cloarec, J L André,[...]. Clin Pharmacol Ther 2009
124
9



Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
Jean-Baptiste Woillard, Jean Debord, Caroline Monchaud, Franck Saint-Marcoux, Pierre Marquet. Clin Pharmacokinet 2017
28
9

Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
Jian-wei Yang, Sha-sha Liao, Li-qin Zhu, Yang Zhao, Yuan Zhang, Xiao-ye Sun, Wei Rao, Wei Qu, Wen-zhuo Li, Li-ying Sun. Int J Clin Pharmacol Ther 2015
29
9

Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
Vanessa Guy-Viterbo, Henry Baudet, Laure Elens, Vincent Haufroid, Florence Lacaille, Muriel Girard, Dominique Debray, Christophe Chardot, Raymond Reding, Pierre Wallemacq,[...]. Pharmacogenomics 2014
24
9

Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy.
M J García Sánchez, C Manzanares, D Santos-Buelga, A Blázquez, J Manzanares, P Urruzuno, E Medina. Clin Pharmacokinet 2001
40
9


Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.
Yang Dai, Mary F Hebert, Nina Isoherranen, Connie L Davis, Christopher Marsh, Danny D Shen, Kenneth E Thummel. Drug Metab Dispos 2006
219
9

Tacrolimus-induced nephrotoxicity and genetic variability: a review.
Violette M G J Gijsen, Parvaz Madadi, Marie-Pierre Dube, Dennis A Hesselink, Gideon Koren, Saskia N de Wildt. Ann Transplant 2012
43
9

Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea.
Wim Lemahieu, Bart Maes, Kristin Verbeke, Paul Rutgeerts, Karel Geboes, Yves Vanrenterghem. Am J Transplant 2005
88
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.